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Prediction of antigenic regions in a protein will be helpful for a rational approach to the synthesis of peptides 
which may elicit antibodies reactive with the intact protein. Earlier methods are based on the assumption 
that antigenic regions are primarily hydrophilic regions at the surface of the protein molecule. The method 
presented here is based on the amino acid composition of known antigenic regions in 20 proteins which 
is compared with that of 314 proteins [(1978) Atlas of Protein Sequence and Structure, vol. 5, suppl. 3, 363- 
3731. Antigenicity values were derived from the differences between the two data sets. The method was ap- 
plied to bovine ribonuclease, the B-subunit of cholera toxin and herpes simplex virus type 1 glycoprotein 
D. There was a good correlation between the predicted regions and previously determined antigenic regions. 
Antigenicity Prediction Antipeptide antibody Syntheticpeptide 
1. INTRODUCTION 
The preparation of antibodies against synthetic 
protein fragments which are reactive with the in- 
tact protein is a rapidly growing field of investiga- 
tion with many applications, e.g. synthetic vac- 
cines, detection of gene products, isolation of pro- 
teins [l]. 
Methods have been presented to locate 
hydrophilic regions in a protein [2,3], since it was 
argued that antigenic determinants are surface- 
located and often contain charged and polar 
residues [2]. These methods are very useful to ob- 
tain a rough estimate of potentially antigenic 
regions. However, as shown by Hopp and Woods 
[2] not all antigenic regions are hydrophilic and not 
all hydrophilic regions are antigenic. Therefore we 
developed a predictive method based on the 
percentage of each amino acid present in known 
antigenic determinants compared with the percen- 
tage of the amino acids in the average composition 
of a protein. 
The procedure was applied to 3 proteins for 
which partial evidence of antigenic regions was 
previously present, i.e. bovine pancreatic 
ribonuclease [4,5], the B-subunit of cholera toxin 
[6] and the N-terminal part of the herpes simplex 
virus type 1 glycoprotein D (unpublished; [7]). 
2. METHOD 
The observation that in addition to hydrophilic 
amino acids hydrophobic amino acid residues are 
often present in antigenic determinants was the 
starting point of our method. Antigenic deter- 
minants of a number of proteins were analyzed 
with respect to their amino acid composition. Of 
homologous proteins the antigenic determinants of 
only one of the proteins and the amino acid 
residues which differed in these regions were in- 
cluded. Antigenic regions and residues from the 
following 7 proteins [2] were used to determine the 
average composition of an antigenic determinant: 
(1) sperm whale myoglobin (residues 15-22, 
56-62, 94-99, 113-119, 145-151); (2) hen egg 
white lysozyme (residues 5, 7, 13, 14, 33, 34, 62, 
87, 89, 93, 96, 97, 113, 114, 116, 125); in addition, 
residues 65-79 of the lysozyme loop were included 
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1101; (3) ferredoxin from Clostridium 
pasteurianum (residues 1-7, 51-55); (4) bovine 
myelin basic protein (residues 64-73, 74-85, 
113-121, 153-166); (5) human IgG heavy chain 
constant regions (residues of the 214 CHl domain, 
296 and 309 of the CH2 domain and 355-358 of 
the CH3 domain); (6) bovine a-lactalbumin 
(residues 10-18, 60-80, 91-94, 105-117); (7) 
leghemoglobin (residues 15-23, 52-59, 92-98, 
107-l 16, 132-142). In addition, based on other or 
more recently published evidence, the following 
residues were included: (8) horse heart cytochrome 
c and cytochromes c from different species 
(residues 11-15, 44, 46-50, 58-62, 88-92, 96, 
103) [2,8]; (9) human hemoglobin a (residues 
15-23, 49-56, 82-94, 102-107, 121-127) [9]; the 
antigenic regions from human hemoglobin ,13 are 
sufficiently different to be included; (10) human 
hemoglobin fi (residues 13-24, 27-38, 72-84, 
108-119, 134-146) [9]; (11) serum albumin 
(bovine and human); the numbering of human 
serum albumin was used (residues 138-147, 
170-181, 309-315, 360-363, 527-536, 560-566, 
554-557) [9]; (12) tobacco mosaic virus (vulgare) 
coat protein (residues l-10, 34-39, 55-61, 62-68, 
80-90, 105-112, 153-158) [ll]; (13) foot and 
mouth disease virus VP1 (residues 200-213, 
144-159) [12,13]; (14) influenza virus hemag- 
glutinin of type A (residues 91-108) [14]; also in- 
cluded were antigenic residues in the original and 
mutant hemagglutinins detected by monoclonal 
antibodies (residues 53, 133, 143-145, 205) [15]; 
(15) hepatitis B surface antigen (residues 140-146) 
[2,16]; (16) small t-antigen of SV40 (residues 
169-174); middle T-antigen of polyoma virus (C- 
terminal hexapeptide and residues 3 1 l-3 19) 
[ 18,191; (18) Streptococcus pyogenes M protein 
(residues 18-29 of the CB7 fragment) [20]; (19) 
diphtheria toxin (residues 188-201) [21]; (20) 
poliovirus type 1 (Mahoney) and type 3 (Leon) 
VP 1 (residues 95- 103) [22,23]. 
2.1. Antigenicity values 
The percentage of each amino acid in antigenic 
regions is listed in table 1 as well as that of each 
amino acid in the amino acid composition derived 
from the amino acid sequences of 314 families of 
sequences [24]. From these data the relative occur- 
rence of each amino acid in an antigenic region was 
calculated. The antigenicity value of each amino 
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acid was expressed as the log10 relative occurrence 
(see table 1). 
2.2. Computerization and prediction of regions 
for peptide synthesis 
To facilitate analysis of proteins with unknown 
antigenic regions, a program similar to that of 
Hopp and Woods [2] was developed. With this 
program, antigenicity values of regions containing 
a certain number of amino acids can be repetitively 
averaged down the peptide chain. Since the ap- 
proximate size of an antigenic determinant is 6-7 
amino acids, an average group length of 7 was 
chosen. This is also in agreement with evidence [5] 
which shows that in order to produce antipeptide 
antibodies reactive with the intact protein, the pep- 
tide should be at least 7 amino acids long. 
However, a higher immune response can be ob- 
tained with longer peptides [5]. Therefore, regions 
of 7 amino acids with relatively high antigenicity 
values (2 5 x 10m2) are extended to 11-13 amino 
Table 1 
Percentage Percentage Relative Antigenicity 
in anti- in average occurrence valuea (log10 
genie protein relative 
region occurrence) 
Ala 11.2 8.6 1.30 0.115 
GLY 5.5 8.4 0.66 -0.184 
Leu 8.8 1.4 1.19 0.075 
Ser 6.6 7.0 0.94 - 0.026 
Val 6.4 6.6 0.97 - 0.013 
Lys 10.6 6.6 1.61 0.206 
Thr 5.5 6.1 0.90 - 0.045 
Glu 5.1 6.0 0.85 -0.071 
Asp 6.4 5.5 1.16 0.065 
Pro 4.6 5.2 0.89 - 0.053 
Arg 5.6 4.9 1.14 0.058 
Ile 2.3 4.5 0.51 - 0.292 
Asn 3.6 4.3 0.84 - 0.077 
Gln 3.8 3.9 0.97 -0.011 
Phe 2.6 3.6 0.72 -0.141 
Tyr 3.5 3.4 1.03 0.013 
CYs 2.2 2.9 0.76 -0.120 
His 4.1 2.0 2.05 0.312 
Met 0.7 1.7 0.41 - 0.385 
Trp 1.0 1.3 0.77 -0.114 
a Antigenicity values were directly derived from the 
percentages of amino acids 
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acids, depending on the antigenicity values of the 
neighboring residues. 
3. RESULTS AND DISCUSSION 
A total of 606 amino acids from 20 proteins was 
used to determine the average composition of an 
antigenic region. This resulted in the approximate 
composition of an antigenic region, since some of 
the regions have been defined exactly, e.g. 
lysozyme and myoglobin, while from others a 
stretch of 20 amino acids is given which contains 
an antigenic determinant (e.g. lactalbumin). This 
composition was compared with that of 314 pro- 
teins from the Atlas of Protein Sequence and 
Structure 1978 [24]. This composition was chosen 
rather than the most recent data in the Protein Se- 
quence Database [25], because, since 1978, many 
amino acid sequences have been added with signal 
peptides and transmembrane segments. It is 
assumed that these parts of a protein do not play 
a direct role in the antigenicity. Indeed, the 1984 
data set from 2676 proteins shows that 20.3% large 
hydrophobic residues (Leu, Ile, Val) are present, 
instead of 18.5% in 1978. His, Lys, Ala, Leu, Asp 
and Arg, in decreasing order, occur more often in 
an antigenic region than in the average composi- 
tion of 314 proteins. Met, Ile, Gly, Phe, Cys and 
Trp are less frequently found in an antigenic 
region. The other amino acids show a relative oc- 
currence between 0.84 (Asn) and 1.03 (Tyr). 
The antigenicity values were used to predict an- 
tigenic regions of an arbitrary length of 12 amino 
acids in bovine ribonuclease, the B-subunit of 
cholera toxin and herpes simplex virus type 1 
glycoprotein D. The antigenicity plots (- - -) are 
shown in fig.1 and compared with the 
hydrophilicity values ( -) obtained by the 
method of Hopp and Woods [2]. In ribonuclease 
4 antigenic regions were predicted, 1-12, 32-43, 
46-57 and 95-106. From the antigenic reactivity 
of homologous pancreatic ribonuclease with an- 
tiserum directed against bovine ribonuclease A, it 
was deduced that residues 34, 35, 103, 50 and/or 
99 and possibly 19 and 37 are part of antigenic 
reactive regions 141. In addition, it was determined 
recently that antibodies against the N-terminal 
region (residues l-7, l-13 and l-20) reacted with 
intact ribonuclease [5]. 
In the B-subunit of cholera toxin regions 7-18, 
_I . 
-.- i  . 
residue number 
Fig.1. Prediction of antigenic regions in (A) bovine 
ribonuclease, (B) the B-subunit of cholera toxin and (C) 
the N-terminal part of herpes simplex virus type 1 
glycoprotein D. An average group length of 7 amino 
acids was chosen. The antigenicity value of each segment 
of 7 amino acids was plotted at the position of the fourth 
residue (- --). Regions of 12 amino acids (indicated by 
bars) were predicted in the following manner: 
heptapeptides with high antigenicity values (2 5 x lo-‘) 
were, depending on the antigenicity values of 
neighboring residues, extended to 12 amino acids. For 
comparison, the hydrophilicity values obtained by the 
method of Hopp and Woods [2] with an average group 
length of 7 amino acids are shown as a continuous line. 
56-67, 75-86 and 88-99 were predicted. Jacob et 
al. [6] synthesized 6 peptides: 8-20, 30-42, 50-64, 
69-85, 75-85 and 83-97. Immunoprecipitation 
experiments showed that antibodies against pep- 
tides 8-20, SO-64 and 83-97 showed the highest 
cross-reactivity with the intact toxin. Antibodies 
against peptide 50-64 could also neutralize the 
biological activity of the toxin. 
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In the N-terminal part of herpes simplex virus 
type 1 glycoprotein D, regions 1-12, 19-30 and 
84-95 were predicted. Cohen et al. [7] have deter- 
mined that antibodies against 8-23 could 
neutralize virus infectivity. We have synthesized 
peptides 1-13 and 9-21. Antibodies against these 
peptides could neutralize herpesvirus infectivity in 
vitro (unpublished). The antigenicity of 84-95 has 
not yet been investigated. A comparison with the 
method of Hopp and Woods [2] shows that of the 
antigenic regions, 46-57 and 95-106 in 
ribonuclease and 7-18 and 88-99 in cholera toxin 
were not predicted by the latter method. In the 
herpes simplex virus glycoprotein, several peptides 
with amino acid sequences comprising parts of the 
N-terminal amino acid sequence appeared to be 
antigenic [7], which was predicted by both 
methods. All peptides predicted by our method 
turned out to be antigenic, or did contain antigenic 
residues, except for cholera toxin peptide 75-86, 
while the herpes simplex virus peptide 84-95 has 
not yet been investigated. These results show that 
with a high success rate peptides are predicted for 
synthesis which may elicit antibodies reactive with 
the intact protein and in some cases interfere with 
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